Interferon-alpha (IFN-α) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway

被引:0
|
作者
Kaser, A [1 ]
Enrich, B [1 ]
Ludwiczek, O [1 ]
Vogel, W [1 ]
Tilg, H [1 ]
机构
[1] Univ Innsbruck Hosp, Dept Med, Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1999年 / 118卷 / 01期
关键词
interferon-alpha; hepatitis C infection; cytotoxicity; perforin; Fas ligand;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cell-mediated cytotoxicity is exerted via perforin and Fas ligand (FasL). We have recently shown that IFN-alpha up-regulates Fast expression in T cells isolated from healthy volunteers and augments activation-induced T cell death. Since the Fas/FasL system is implicated in the pathogenesis of hepatic failure and both molecules have been shown to be up-regulated in hepatitis C virus (HCV) infection, we studied whether cytotoxicity via the Fast system is enhanced by IFN-alpha and therefore could contribute to hepatic injury. We investigated Fast and perforin expression in peripheral blood mononuclear cells (PBMC) derived from HCV+ donors by Northern analysis and soluble Fast synthesis by ELISA. Natural killer (NK) cell and cytotoxic T lymphocyte (CTL) cytotoxicity was studied by Cr-51-release assays. IFN-alpha up-regulates Fast mRNA and protein synthesis in mitogen-activated PBMC of HCV+ individuals, as previously found in healthy subjects. Stimulation with IFN-alpha increases perforin mRNA levels in PBMC. In NK cytotoxicity assays, the enhancement of cytotoxicity by IFN-alpha is mainly due to the perforin pathway, while the Fast pathway plays only a minor role. In CTL cytotoxicity experiments neither the Fast nor the perforin pathway is further enhanced by IFN-alpha. Our data suggest that upregulation of perforin by IFN-alpha results in elevated cytotoxicity, suggesting that IFN-alpha might support elimination of virally infected cells via this pathway. In contrast, the major effect of IFN-alpha on the Fas/FasL system might be the enhanced elimination of activated T cells as a means of finally limiting a T cell response.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 50 条
  • [1] Liposomal lactoferrin induced significant increase of the interferon-alpha (IFN-α) producibility in healthy volunteers
    Ishikado, A
    Imanaka, H
    Kotani, M
    Fujita, A
    Mitsuishi, Y
    Kanemitsu, T
    Tamura, Y
    Makino, T
    BIOFACTORS, 2004, 21 (1-4) : 69 - 72
  • [2] A new strategy for chronic hepatitis C infection using interferon-alpha (IFN alpha) and glycyrrhizin compounds
    Shibasaki, K
    Soga, K
    Toshima, M
    Aikawa, K
    GUT, 1997, 41 : A132 - A132
  • [3] BIOPSYCHOSOCIAL CONSEQUENCES OF INTERFERON-ALPHA (IFN-ALPHA) THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
    Baranyi, A.
    Meinitzer, A.
    Stepan, A.
    Matejka, J.
    Stauber, R.
    Rothenhaeusler, H. -B.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [4] Outcome of interferon-alpha (IFN-α) treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C
    Tokumoto, T
    Tanabe, K
    Oshima, T
    Ishikawa, N
    Shinmura, H
    Yagisawa, T
    Hashimoto, E
    Fuchinoue, S
    Hayashi, N
    Toma, H
    TRANSPLANTATION, 1999, 67 (07) : S99 - S99
  • [5] Recombinant interferon-alpha (IFN-alpha) in chronic hepatitis C in hemophiliacs with or without HIV infection.
    Silvain, C
    Pol, S
    Sogni, P
    Capron, D
    Delumley, L
    Sultan, Y
    Alcalay, M
    Hosterer, G
    Agius, G
    HEPATOLOGY, 1999, 30 (04) : 620A - 620A
  • [6] Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-α) in Slovenia
    Brinovec, V
    Lesnicar, G
    Maticic, M
    Meglic-Volkar, J
    Poljak, M
    Seme, K
    Ferlan-Marolt, V
    HEPATO-GASTROENTEROLOGY, 2002, 49 (47) : 1320 - 1325
  • [7] PREDICTORS OF RESPONSE TO INTERFERON-ALPHA (IFN) THERAPY IN CHRONIC HEPATITIS-C
    BENNETT, WG
    ORITO, E
    MIZOKAM, M
    LA, JYN
    GASTROENTEROLOGY, 1995, 108 (04) : A1034 - A1034
  • [8] Interferon-alpha treatment of chronic hepatitis C virus infection in children
    Jonas, MM
    Ott, MJ
    Nelson, SP
    Badizadegan, K
    Perez-Atayde, AR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) : 241 - 246
  • [9] Interferon-alpha in chronic hepatitis-C
    Rabe, C
    Holstege, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 121 (06) : 187 - 187
  • [10] SUPPRESSED GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION IN CHRONIC HEPATITIS C PATIENTS ON INTERFERON-ALPHA(IFN-α) THERAPY; POSSIBLE ROLE IN IFN-α INDUCED NEUTROPENIA
    Tjuddin, Tariq
    Ryan, Elizabeth
    Keogh, Catherine
    Norris, Suzanne
    O'Farrelly, Cliona
    Hegarty, John
    LIVER TRANSPLANTATION, 2008, 14 (07) : S228 - S229